Publications in collaboration with researchers from Ingalls Memorial Hospital (2)

2019

  1. TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer

    Cancer Chemotherapy and Pharmacology

2018

  1. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    British Journal of Cancer, Vol. 119, Núm. 10, pp. 1208-1214